Trials / Completed
CompletedNCT02256306
The PLasma for Alzheimer SymptoM Amelioration (PLASMA) Study
The PLasma for Alzheimer SymptoM Amelioration (PLASMA) Study: Intravenously-Administered Plasma From Young Donors for Treatment of Mild-To-Moderate Alzheimer's Disease
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- Stanford University · Academic / Other
- Sex
- All
- Age
- 50 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
The PLasma for Alzheimer SymptoM Amelioration (PLASMA) Study: Intravenously-Administered Plasma From Young Donors for Treatment of Mild-To-Moderate Alzheimer's Disease
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Plasma | 1 unit of Plasma From Young Donors (Male, aged 30 or younger) |
Timeline
- Start date
- 2014-09-01
- Primary completion
- 2017-02-01
- Completion
- 2017-02-01
- First posted
- 2014-10-03
- Last updated
- 2017-10-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02256306. Inclusion in this directory is not an endorsement.